Polycystic ovarian syndrome (PCOS) is one of the most common human ova
rian pathologies affecting women of reproductive age. Despite extensiv
e investigation, the etiology of PCOS remains poorly understood. Exper
imentally, a PCO-like syndrome can be induced in rodents by a single d
ose of the long-acting estrogen, estradiol valerate (EV). We have used
this model to examine the possibility that PCOS is associated with de
rangement of the sympathetic control of the ovary. The release of newl
y incorporated norepinephrine (NE) from ovarian nerve terminals in res
ponse to transmural stimulation of the gland increased significantly b
efore the formation of cysts (30 days after EV injection) and remained
elevated at the time when cysts form (60 days). The increase in evoke
d NE release was accompanied by an augmented NE content and enhanced i
ncorporation of [H-3]NE into ovarian tissue; both of these changes had
been initiated by 30 days after EV treatment and became unambiguous a
t the time of cyst formation. The overall increase in ovarian sympathe
tic outflow suggested by these alterations in catecholamine homeostasi
s was accompanied by a thecal cell-interstitial tissue selective down-
regulation of beta-adrenergic receptors; the beta-adrenergic receptor
concentration in these sympathetically innervated ovarian compartments
was significantly lower in PCO than during the estrous phase of the e
strous cycle, a time at which the beta-adrenergic receptor concentrati
on reaches its lowest levels in normal cycling ovaries. Tyrosine hydro
xylase activity was found to increase only when expressed per mg ovary
, but not in absolute terms (i.e. per total ovary), suggesting regulat
ion of enzyme activity by the enhanced catecholamine content. The resu
lts demonstrate that an activation of the sympathetic neurons innervat
ing the ovary precedes the development of cysts in EV-induced PCOS and
raise the possibility that a derangement of sympathetic inputs to the
ovary contributes to the etiology of PCOS.